Revance Therapeutics Depreciation & Amortization 2011-2026 | RVNC

Annual Depreciation & Amortization Revance Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.4 M	33.7 M	19.9 M	10.2 M	2.91 M	1.73 M	1.47 M	1.44 M	2 M	2.05 M	1.88 M	1.78 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
33.7 M	1.44 M	7.54 M

Quarterly Depreciation & Amortization Revance Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
545 K	546 K	1.98 M	-	374 K	717 K	4.3 M	-	3.88 M	3.93 M	5.38 M	-	14.4 M	9.28 M	4.24 M	-	5.93 M	2.15 M	739 K	-	2.15 M	1.42 M	628 K	-	1.25 M	807 K	390 K	-	1.1 M	722 K	357 K	-	1.07 M	699 K	344 K	-	1.59 M	1.08 M	531 K	-	600 K	500 K	488 K	-	400 K	400 K	453 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.4 M	344 K	2.09 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptorum Group Limited APM	1.13 M	$ 0.81	0.15 %	$ 4.42 M	China
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	229 K	$ 1.24	-0.8 %	$ 1.83 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
BioMarin Pharmaceutical BMRN	96.4 M	$ 61.58	-1.66 %	$ 11.7 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Atea Pharmaceuticals AVIR	416 K	$ 4.56	-1.94 %	$ 384 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Capricor Therapeutics CAPR	1.07 M	$ 28.24	1.18 %	$ 756 M	USA
Axsome Therapeutics AXSM	503 K	$ 165.14	-2.83 %	$ 8.22 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
CASI Pharmaceuticals CASI	468 K	$ 0.31	-61.59 %	$ 42.2 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	1.07 M	$ 12.21	-3.48 %	$ 804 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	780 M	$ 191.78	-1.72 %	$ 28.1 B	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Amneal Pharmaceuticals AMRX	62.6 M	$ 14.64	-0.17 %	$ 4.52 B	USA